Bristol Myers Squibb (BMY) Capital Expenditures (2009 - 2026)
Bristol Myers Squibb's Capital Expenditures came in at $344 million for Q3 2026, up 7.5% from $320 million a year earlier and up 12.8% from the prior quarter.
Bristol Myers Squibb (BMY) Capital Expenditures (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Bristol Myers Squibb reported Capital Expenditures of $1.37 billion, up 3.6% year-over-year; for FY2025, it was $1.31 billion, up 5.0% from FY2024.
- Capital Expenditures has increased in each of the last five years, with a five-year compound annual growth rate of 11.7% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $1.25 billion in FY2024 (+3.2%), $1.21 billion in FY2023 (+8.1%), $1.12 billion in FY2022 (+14.9%) and $973 million in FY2021 (+29.2%).
- The five-year range for quarterly Capital Expenditures is $247 million (Q3 2022) to $378 million (Q4 2024).
- Year-over-year, Capital Expenditures increased in four of the last eight quarters, with growth averaging 8.2%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q1 2022 (growth of 46.2%), and the weakest in Q2 2026 (a decline of 15.5%).
- Business Quant data shows BMY's Capital Expenditures at $305 million (Q2 2026), $347 million (Q1 2026) and $370 million (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Bristol Myers Squibb | 128.63 Bn | 83.82 Bn | 8.92 Bn | 344.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 344.00 Mn |
| Jun 30, 2026 | 305.00 Mn |
| Mar 31, 2026 | 347.00 Mn |
| Dec 31, 2025 | 370.00 Mn |
| Sep 30, 2025 | 320.00 Mn |
| Jun 30, 2025 | 361.00 Mn |
| Mar 31, 2025 | 260.00 Mn |
| Dec 31, 2024 | 378.00 Mn |
| Sep 30, 2024 | 324.00 Mn |
| Jun 30, 2024 | 262.00 Mn |
| Mar 31, 2024 | 284.00 Mn |
| Dec 31, 2023 | 330.00 Mn |
| Sep 30, 2023 | 342.00 Mn |
| Jun 30, 2023 | 259.00 Mn |
| Mar 31, 2023 | 278.00 Mn |
| Dec 31, 2022 | 346.00 Mn |
| Sep 30, 2022 | 247.00 Mn |
| Jun 30, 2022 | 272.00 Mn |
| Mar 31, 2022 | 253.00 Mn |
| Dec 31, 2021 | 320.00 Mn |
Bristol Myers Squibb Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();